Bahçeşehir University has announced a clinical study investigating the effects of immersive virtual reality-based therapy on patients diagnosed with Grade 1–2 adhesive capsulitis, also known as frozen shoulder. The trial aims to compare conventional physiotherapy treatments with innovative VR-based exercise therapy to assess outcomes related to pain management, sleep quality, and cognitive functions. Recruitment is scheduled to commence soon, offering valuable insight for clinical, regulatory, and research professionals. The results may influence the future of physiotherapeutic interventions.
In this article:
- What changed?
- About the clinical trial
- Study design and scope
- Frequently asked questions
- Conclusion
- Disclaimer
- Announcement details
What changed?
The clinical trial remains in the “Not yet recruiting” phase but represents an important step in exploring advanced physiotherapy interventions for adhesive capsulitis. The introduction of immersive virtual reality-based exercise therapy differentiates this study by incorporating emerging technology to potentially enhance patient outcomes.
Stakeholders such as clinical teams, regulatory professionals, and manufacturers in rehabilitation medicine should monitor the progress closely, as groundbreaking results could reshape therapeutic protocols and compliance strategies.
About the clinical trial
Adhesive capsulitis is a debilitating condition characterized by stiffness and pain in the shoulder joint. Conventional physiotherapy remains a standard treatment; however, this study introduces a comparison using virtual reality-based exercise therapy. Researchers are evaluating pain reduction, sleep improvements, and cognitive engagement as trial outcomes.
The trial will be sponsored by Bahçeşehir University. Patients categorized as Grade 1–2 adhesive capsulitis candidates will be enrolled, with detailed results expected to highlight the feasibility of introducing VR-based methods into mainstream physiotherapy.
Study design and scope
Key objectives
The study primarily seeks to determine the efficacy and safety of using immersive VR tools compared to conventional physiotherapy methods. Patient progress will be evaluated based on measurable improvements in sleep, pain levels, and cognitive function.
Patient groups
Two distinct cohorts will participate:
- Conventional Physiotherapy Group: Patients undergoing standard physiotherapeutic exercises for adhesive capsulitis.
- Immersive Virtual Reality-Based Therapy Group: Patients engaging in technology-enhanced interventions utilizing immersive VR platforms.
Sponsored oversight
Bahçeşehir University will oversee the trial execution, ensuring compliance with clinical and regulatory standards throughout every stage of the study.
Frequently asked questions
1. What benefits does VR therapy offer compared to conventional methods?
Immersive virtual reality therapy potentially enhances patient engagement, reduces pain perception, and stimulates cognitive functions in ways conventional physiotherapy alone may not achieve.
2. Can this study impact clinical guidelines for physiotherapy?
If successful, results may influence both clinical guidelines and regulatory updates, encouraging the integration of VR tools into physiotherapeutic practices.
3. When will recruitment begin?
The trial is marked as “Not yet recruiting,” with future updates expected from Bahçeşehir University.
Conclusion
This upcoming virtual reality-based exercise therapy research offers substantive implications for adhesive capsulitis treatments and beyond. Clinical professionals, quality assurance teams, and regulatory authorities should remain informed as this study unfolds. Advancements in technology-driven interventions may soon redefine rehabilitation practices globally.
Disclaimer
The content provided here serves informational purposes only and does not constitute legal, clinical, or regulatory advice. Professionals are urged to refer to official guidelines for compliance measures.
Announcement details
For full information about the announcement, see the link below.
https://clinicaltrials.gov/study/NCT07236229?term=medical+device